PT2513115E - Antibióticos tricíclicos - Google Patents
Antibióticos tricíclicosInfo
- Publication number
- PT2513115E PT2513115E PT107932550T PT10793255T PT2513115E PT 2513115 E PT2513115 E PT 2513115E PT 107932550 T PT107932550 T PT 107932550T PT 10793255 T PT10793255 T PT 10793255T PT 2513115 E PT2513115 E PT 2513115E
- Authority
- PT
- Portugal
- Prior art keywords
- mdash
- substituted
- independently
- nitrogen
- another
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- C07D491/052—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being six-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/14—Ortho-condensed systems
- C07D491/147—Ortho-condensed systems the condensed system containing one ring with oxygen as ring hetero atom and two rings with nitrogen as ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/14—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Pharmacology & Pharmacy (AREA)
- Communicable Diseases (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP09179956 | 2009-12-18 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT2513115E true PT2513115E (pt) | 2013-12-19 |
Family
ID=41716611
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT107932550T PT2513115E (pt) | 2009-12-18 | 2010-12-17 | Antibióticos tricíclicos |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US8927541B2 (pt) |
| EP (1) | EP2513115B1 (pt) |
| JP (1) | JP5697685B2 (pt) |
| KR (1) | KR101891834B1 (pt) |
| CN (1) | CN102666548B (pt) |
| AU (1) | AU2010332767B2 (pt) |
| BR (1) | BR112012014519A8 (pt) |
| CA (1) | CA2780006A1 (pt) |
| CY (1) | CY1114802T1 (pt) |
| DK (1) | DK2513115T3 (pt) |
| ES (1) | ES2441348T3 (pt) |
| HK (1) | HK1174026A1 (pt) |
| HR (1) | HRP20140005T1 (pt) |
| MX (1) | MX2012006094A (pt) |
| PL (1) | PL2513115T3 (pt) |
| PT (1) | PT2513115E (pt) |
| SI (1) | SI2513115T1 (pt) |
| TW (1) | TWI487709B (pt) |
| WO (1) | WO2011073378A1 (pt) |
| ZA (1) | ZA201203540B (pt) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2721034B1 (en) * | 2011-06-17 | 2016-07-20 | Basilea Pharmaceutica AG | N-heterotricyclic antibiotics |
| AR090880A1 (es) * | 2012-04-30 | 2014-12-10 | Janssen R & D Ireland | Derivados de pirimidina |
| GB201406486D0 (en) | 2014-04-10 | 2014-05-28 | Redx Pharma Ltd | Antibacterial compounds |
| WO2016105468A1 (en) * | 2014-12-23 | 2016-06-30 | Proteostasis Therapeutics, Inc. | Derivatives of 3-heteroarylisoxazol-5-carboxylic amide useful for the treatment of inter alia cystic fibrosis |
| CN110177796B (zh) * | 2017-01-06 | 2022-04-08 | 阿斯克里斯有限公司 | 喹啉酮衍生物及其用于预防或治疗变应性疾病的药物组合物 |
| AU2023235233A1 (en) | 2022-03-14 | 2024-09-12 | Slap Pharmaceuticals Llc | Multicyclic compounds |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5430148A (en) | 1992-03-31 | 1995-07-04 | Agouron Pharmaceuticals, Inc. | Antiproliferative quinazolines |
| US6939871B2 (en) | 2000-10-26 | 2005-09-06 | Smithkline Beecham P.L.C. | Benzoxazinone derivatives, their preparation and use |
| TW200406413A (en) | 2002-06-26 | 2004-05-01 | Glaxo Group Ltd | Compounds |
| AR042486A1 (es) | 2002-12-18 | 2005-06-22 | Glaxo Group Ltd | Compuesto de quinolina y naftiridina halosustituido en la posicion 3, procedimiento para preparar el compuesto, composicion farmaceutica que lo comprende y su uso para preparar dicha composicion . |
| US7037909B2 (en) | 2003-07-02 | 2006-05-02 | Sugen, Inc. | Tetracyclic compounds as c-Met inhibitors |
| JP2007513082A (ja) | 2003-11-10 | 2007-05-24 | シエーリング アクチエンゲゼルシャフト | Ｃｃｒ−５アンタゴニストとして有用なベンジルエーテルアミン化合物 |
| GB0403038D0 (en) | 2004-02-11 | 2004-03-17 | Novartis Ag | Organic compounds |
| EP1773831A1 (en) * | 2004-07-08 | 2007-04-18 | Glaxo Group Limited | Antibacterial agents |
| DE102004041163A1 (de) | 2004-08-25 | 2006-03-02 | Morphochem Aktiengesellschaft für kombinatorische Chemie | Neue Verbindungen mit antibakterieller Aktivität |
| WO2006038734A1 (en) | 2004-10-08 | 2006-04-13 | Astellas Pharma Inc. | Pyridazinone derivatives cytokines inhibitors |
| TW200615273A (en) * | 2004-11-10 | 2006-05-16 | Nicholas Piramal India Ltd | Fused tricyclic compounds as inhibitors of tumor necrosis factor-alpha |
| JP5023054B2 (ja) | 2005-03-31 | 2012-09-12 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | 抗バクテリア剤としての二環式ピラゾール化合物 |
| WO2007052843A1 (ja) | 2005-11-04 | 2007-05-10 | Takeda Pharmaceutical Company Limited | 複素環アミド化合物およびその用途 |
| EP1996563B1 (en) | 2006-02-13 | 2012-03-21 | F. Hoffmann-La Roche AG | Heterobicyclic sulfonamide derivatives for the treatment of diabetes |
| GB0613208D0 (en) | 2006-07-03 | 2006-08-09 | Glaxo Group Ltd | Compounds |
| GB0707708D0 (en) * | 2007-04-20 | 2007-05-30 | Glaxo Group Ltd | Compounds |
| WO2009012647A1 (fr) | 2007-07-20 | 2009-01-29 | Shanghai Hengrui Pharmaceutical Co., Ltd. | Procédés de préparation de dérivés de quinazoline et leurs utilisations pharmaceutiques |
| WO2009125809A1 (ja) | 2008-04-11 | 2009-10-15 | 第一三共株式会社 | ピペリジン誘導体 |
| WO2009125808A1 (ja) * | 2008-04-11 | 2009-10-15 | 第一三共株式会社 | アミノシクロヘキシル誘導体 |
| TW200944529A (en) * | 2008-04-15 | 2009-11-01 | Actelion Pharmaceuticals Ltd | Tricyclic antibiotics |
| DE102008028996B4 (de) | 2008-06-20 | 2011-06-09 | Technische Universität Braunschweig | Verfahren zur Nachbehandlung einer Schweißverbindung |
| RU2011108008A (ru) | 2008-08-04 | 2012-09-10 | Актелион Фармасьютиклз Лтд (Ch) | Производные трициклического алкиламинометилоксазолидинона |
-
2010
- 2010-12-17 JP JP2012543782A patent/JP5697685B2/ja not_active Expired - Fee Related
- 2010-12-17 SI SI201030487T patent/SI2513115T1/sl unknown
- 2010-12-17 PL PL10793255T patent/PL2513115T3/pl unknown
- 2010-12-17 KR KR1020127018328A patent/KR101891834B1/ko active IP Right Grant
- 2010-12-17 MX MX2012006094A patent/MX2012006094A/es active IP Right Grant
- 2010-12-17 TW TW099144554A patent/TWI487709B/zh not_active IP Right Cessation
- 2010-12-17 AU AU2010332767A patent/AU2010332767B2/en not_active Ceased
- 2010-12-17 ES ES10793255.0T patent/ES2441348T3/es active Active
- 2010-12-17 EP EP10793255.0A patent/EP2513115B1/en active Active
- 2010-12-17 BR BR112012014519A patent/BR112012014519A8/pt not_active Application Discontinuation
- 2010-12-17 US US13/511,292 patent/US8927541B2/en active Active - Reinstated
- 2010-12-17 WO PCT/EP2010/070043 patent/WO2011073378A1/en active Application Filing
- 2010-12-17 DK DK10793255.0T patent/DK2513115T3/da active
- 2010-12-17 CA CA2780006A patent/CA2780006A1/en not_active Abandoned
- 2010-12-17 CN CN201080057649.7A patent/CN102666548B/zh active Active
- 2010-12-17 PT PT107932550T patent/PT2513115E/pt unknown
-
2012
- 2012-05-15 ZA ZA2012/03540A patent/ZA201203540B/en unknown
-
2013
- 2013-01-22 HK HK13100956.7A patent/HK1174026A1/xx not_active IP Right Cessation
- 2013-12-27 CY CY20131101172T patent/CY1114802T1/el unknown
-
2014
- 2014-01-03 HR HRP20140005AT patent/HRP20140005T1/hr unknown
- 2014-11-18 US US14/546,589 patent/US9120822B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| AU2010332767A1 (en) | 2012-05-24 |
| TW201132645A (en) | 2011-10-01 |
| ZA201203540B (en) | 2013-01-30 |
| CY1114802T1 (el) | 2016-12-14 |
| TWI487709B (zh) | 2015-06-11 |
| HRP20140005T1 (hr) | 2014-01-31 |
| KR101891834B1 (ko) | 2018-09-28 |
| PL2513115T3 (pl) | 2014-04-30 |
| BR112012014519A8 (pt) | 2017-12-26 |
| WO2011073378A1 (en) | 2011-06-23 |
| BR112012014519A2 (pt) | 2016-08-16 |
| CN102666548A (zh) | 2012-09-12 |
| SI2513115T1 (sl) | 2014-02-28 |
| DK2513115T3 (da) | 2014-01-13 |
| HK1174026A1 (en) | 2013-05-31 |
| US20120245345A1 (en) | 2012-09-27 |
| CA2780006A1 (en) | 2011-06-23 |
| US8927541B2 (en) | 2015-01-06 |
| JP5697685B2 (ja) | 2015-04-08 |
| KR20120101711A (ko) | 2012-09-14 |
| EP2513115A1 (en) | 2012-10-24 |
| EP2513115B1 (en) | 2013-10-09 |
| JP2013514331A (ja) | 2013-04-25 |
| AU2010332767B2 (en) | 2014-04-24 |
| ES2441348T3 (es) | 2014-02-04 |
| US9120822B2 (en) | 2015-09-01 |
| CN102666548B (zh) | 2015-07-15 |
| MX2012006094A (es) | 2012-06-19 |
| US20150072975A1 (en) | 2015-03-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT2513115E (pt) | Antibióticos tricíclicos | |
| MX2012007420A (es) | Analogos para el tratamiento o prevencion de infecciones de flavivirus. | |
| MX2010004893A (es) | Compuesto heterociclico y composicion farmaceutica del mismo. | |
| MX2013006101A (es) | Compuestos heterociclicos nitrogenados sustituidos fusionados en posicion 6,6 y usos de los mismos. | |
| MX2017010230A (es) | Derivados de mono- y poliazanaftaleno sustituidos y su uso. | |
| MX2008012399A (es) | Modulacion de cinasa de ceramida. | |
| GEP20125581B (en) | Sulfonyl amide derivatives for treatment of abnormal cell growth | |
| MX2010006421A (es) | Compuestos organicos. | |
| NZ593892A (en) | Antibiotic compositions for the treatment of gram negative infections | |
| MX2009003073A (es) | Derivado de 2-piridincarboxamida que tiene efecto activador de gk. | |
| MY147390A (en) | Substituted isoindoles as bace inhibitors and their use | |
| AR074608A1 (es) | Derivados de 2-(piperidin-1-il)-4-heterociclil-tiazol-5-carboxilico para infecciones bacterianas | |
| EP1885722A4 (en) | QUINOLINE DERIVATIVES AS EP4 ANTAGONISTS | |
| MY157116A (en) | Novel seh inhibitors and their use | |
| UA105786C2 (uk) | Адитивні солі амінів, що містять гідроксильні і/або карбоксильні групи, з похідними амінонікотинової кислоти як інгібітори dhodh | |
| DK1961734T3 (da) | Aminforbindelse og anvendelse deraf til medicinske formål | |
| IN2012DN03129A (pt) | ||
| MX2009007713A (es) | Derivados de piridazina, procedimientos para su preparacion y su uso como fungicidas. | |
| MX2010008361A (es) | Derivados de arilamida oxazepinopirimidona sustituidos. | |
| MY169179A (en) | Novel piperidine compound or salt thereof | |
| TN2010000038A1 (en) | Organic compounds | |
| ATE494308T1 (de) | Neue derivate von hyaluronsäure, herstellungsverfahren dafür und verwendungen davon | |
| MX2009009466A (es) | Compuestos triciclicos de utilidad en el tratamiento de trastornos del hierro. | |
| MX2018011721A (es) | Compuesto de griseofulvina. | |
| FR2942625B1 (fr) | Derives indoliques pour le traitement de maladies neurodegeneratives |